From: Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey
Study author, online publication datea | Location | ICU patients with ARDS | ICU patients who received IMV | Mortality ICU patients | Mortality ARDS patients | Mortality IMV patients | Prevalence of ARDS in non-survivors |
---|---|---|---|---|---|---|---|
Dreher M, 17/4 | Aachen, Germany | 24/24 (100) | 24/24 (100) | 3/24 (13) | 3/24 (13) | 3/24 (13) | 3/7 (43) |
Yao Q, 24/4 | Huanggang, China | 17/17 (100) | 10/17 (59) | 12/17 (71) | 12/45 (27) | 10/10 (100) | 12/12 (100) |
Hong K, 11/5 | Daegu, South Korea | 13/13 (100) | 11/13 (85) | 4/13 (31) | 4/18 (22) | NA | 4/5 (80) |
Xu X,19/2 | Zhejiang, China | 1/1 (100) | 1/1 (100) | 0/1 (0) | 0/1 (0) | 0/1 (0) | NA |
Wu C, 13/3 | Wuhan, China | NA | 6/53 (11) | NA | 44/84 (52) | 6/6 (100) | 44/44 (100) |
Zhou F, 11/3 | Wuhan, China | NA | NA | 39/50 (78) | 50/59 (85) | 31/32 (97) | 50/54 (93) |
Zheng Y, 10/4 | Chengdu, China | 15/32 (47) | NA | 3/32 (9) | 3/15 (20) | NA | 3/3 (100) |
Suleyman G, 1/6 | Detroit, Michigan, USA | 104/141 (74) | 114/141 (81) | 57/141 (40) | NA | 52/114 (46) | NA |
Huang C, 24/1 | Wuhan, China | 11/13 (85) | 4/13 (31) | 5/13 (38) | NA | NA | NA |
Wang D, 7/2 | Wuhan, China | 22/36 (61) | 21/36 (58) | 6/36 (17) | NA | NA | NA |
Yang L, 26/5 | Yichang, China | 21/29 (72) | 16/29 (55) | 14/29 (48) | NA | NA | NA |
Chen T, 26/3 | Wuhan, China | NA | NA | NA | 113/196 (58) | 17/17 (100) | 113/113 (100) |
Aggarwal S, 26/4 | Des Moines, Iowa, USA | NA | 5/8 (63) | 3/8 (38) | NA | NA | NA |
Inciardi R, 8/5 | Brescia, Italy | NA | NA | NA | 17/19 (89) | NA | 17/26 (65) |
Chen N, 30/1 | Wuhan, China | NA | NA | NA | 11/17 (65) | NA | 11/11 (100) |
Ciceri F, 12/6 | Milan, Italy | NA | NA | NA | 65/245 (27) | NA | 65/82 (79) |
Yu T, 27/4 | Dongguan, China | NA | NA | NA | NA | NA | NA |
Total (weighted average) | Â | 228/306 (75) | 212/335 (63) | 146/363 (40) | 322/722 (45) | 119/203 (59) | 322/357 (90) |